Parkside Financial Bank & Trust Guardant Health, Inc. Transaction History

Parkside Financial Bank & Trust

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$20.94 - $38.01 $167 - $304	8 Added 19.05%	50 $1,000
Q1 2023 May 04, 2023	SELL	$22.92 - $33.76 $160 - $236	-7 Reduced 14.29%	42 $0
Q4 2022 Feb 13, 2023	SELL	$25.44 - $59.78 $330 - $777	-13 Reduced 20.97%	49 $1,000
Q2 2022 Jul 13, 2022	BUY	$28.82 - $77.35 $864 - $2,320	30 Added 93.75%	62 $3,000
Q1 2022 May 13, 2022	BUY	$48.25 - $100.49 $1,447 - $3,014	30 Added 1500.0%	32 $3,000
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $975 - $1,324	-11 Reduced 84.62%	2 $0
Q3 2021 Oct 29, 2021	SELL	$98.77 - $132.17 $691 - $925	-7 Reduced 35.0%	13 $2,000
Q2 2021 Aug 06, 2021	SELL	$109.77 - $165.68 $1,427 - $2,153	-13 Reduced 39.39%	20 $2,000
Q3 2020 Nov 06, 2020	SELL	$80.32 - $111.8 $240 - $335	-3 Reduced 8.33%	33 $4,000
Q2 2020 Aug 10, 2020	BUY	$60.49 - $97.5 $2,177 - $3,510	36 New	36 $3,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.97B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Parkside Financial Bank & Trust with notifications on news.